Niagen Bioscience (NAGE) Net Margin Growth (1y) (2011 - 2026)

Niagen Bioscience (NAGE) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Niagen Bioscience 253.47 Mn 186.92 Mn 19.98 Mn 346.00

Historic Data

Download Data
DateValue
Mar 31, 2026 346.00
Dec 31, 2025 -1,244.00
Sep 30, 2025 613.00
Jun 30, 2025 1,166.00
Mar 31, 2025 1,883.00
Dec 31, 2024 2,592.00
Sep 30, 2024 3,501.00
Jun 30, 2024 3,336.00
Mar 31, 2024 2,738.00
Dec 31, 2023 625.00
Sep 30, 2023 1,988.00
Jun 30, 2023 3,624.00
Mar 31, 2023 1,809.00
Dec 31, 2022 1,976.00
Sep 30, 2022 836.00
Jun 30, 2022 -1,495.00
Mar 31, 2022 455.00
Dec 31, 2021 1,210.00
Sep 30, 2021 -2,428.00
Jun 30, 2021 -2,966.00